| abstract |
As used herein, methods, compositions, and kits for treating myeloproliferative disorders or neoplasms, including polycythemia vera, primary myelofibrosis, thrombocythemia, and essential thrombocythemia, Provided. Methods for treating cancer are also provided herein. Such methods can include the use of JAK inhibitors and PI3K inhibitors. Such methods can include the use of anti-CD20 antibodies and PI3K inhibitors. Related compositions, articles of manufacture and kits are also provided herein. |